Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR4 | P61073 | 6/20 | 0.43 |
| ▸ | NMUR2 | Q9GZQ4 | 4/20 | 0.40 |
| ▸ | NMUR1 | Q9HB89 | 4/20 | 0.40 |
| ▸ | REN | P00797 | 3/20 | 0.40 |
| ▸ | ACE | P12821 | 3/20 | 0.40 |
| ▸ | EPHA2 | P29317 | 2/20 | 0.40 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.38 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.38 |
| ▸ | MC4R | P32245 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29630805 | 0.94 | BDKRB2 (0.41) | CXCR4NMUR2NMUR1RENACE | |
| SCHEMBL31303209 | 0.94 | CXCR4 (0.43) | CXCR4NMUR2NMUR1EPHA2OPRM1 | |
| SCHEMBL30866232 | 0.92 | ACE (0.44) | CXCR4RENACEEPHA2OPRM1 | |
| SCHEMBL31303212 | 0.91 | CXCR4 (0.50) | CXCR4NMUR2NMUR1MC4R | |
| SCHEMBL31437157 | 0.90 | KEAP1 (0.43) | CXCR4NMUR2NMUR1RENACE | |
| SCHEMBL29597171 | 0.90 | CXCR4 (0.46) | CXCR4NMUR2NMUR1EPHA2OPRM1 | |
| SCHEMBL8628213 | 0.88 | CXCR4 (0.46) | CXCR4NMUR2NMUR1EPHA2OPRM1 | |
| SCHEMBL30688240 | 0.88 | NMUR2 (0.41) | CXCR4NMUR2NMUR1RENACE | |
| SCHEMBL30104718 | 0.86 | CXCR4 (0.46) | CXCR4NMUR2NMUR1EPHA2OPRM1 | |
| SCHEMBL31437194 | 0.86 | ACE (0.42) | CXCR4RENACEEPHA2OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025037992-A1 | NEW PEPTIDES AND USE THEREOF | MAJEWSKI FILIP (PL) | 2025-02-20 | — | — | WO | disclosed |
| WO-2025037993-A1 | DOSAGE FORM FOR PEPTIDE AGENTS | MAJEWSKI FILIP (PL) | 2025-02-20 | — | — | WO | disclosed |